Αρχειοθήκη ιστολογίου

Πέμπτη 27 Ιουλίου 2017

MYSTIC trial of durvalumab ± tremelimumab targeting PD1 and CTLA4 fails to extend PFS compared to SOC chemotherapy… https://t.co/8O6eZInLyQ

MYSTIC trial of durvalumab ± tremelimumab targeting PD1 and CTLA4 fails to extend PFS compared to SOC chemotherapy… https://t.co/8O6eZInLyQ

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/890523521452875776
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader